What's happening
This bill requires health insurance policies in New York to cover human leukocyte antigen (HLA) testing for bone marrow tissue typing.
Why it matters
Expands access to life-saving bone marrow transplants. By requiring insurance coverage for HLA testing, the bill removes a key financial barrier for patients and potential donors, making it easier to identify compatible matches for those in need of bone marrow transplants.
Promotes early diagnosis and treatment of serious diseases. HLA testing is critical for conditions like leukemia and other blood disorders; insurance coverage could lead to earlier tissue typing, faster donor identification, and improved patient outcomes.
Reduces out-of-pocket costs and health disparities. Without mandated coverage, HLA testing can be expensive, potentially excluding lower-income individuals from the donor registry or from receiving timely transplants; this bill helps address such inequities.
Excludes certain employer-based and multi-state insurance plans. The bill does not apply to insurance policies covering employees in more than one state or those shaped by multi-state collective bargaining, meaning some workers may still lack this coverage.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Health insurers and health service corporations
The bill would require covered policies and contracts to pay for human leukocyte antigen testing for A, B and DR antigens used in tissue typing for bone marrow testing.
Patients undergoing bone marrow tissue typing
Those enrolled in covered policies would gain required coverage for the specified antigen testing.
Laboratories performing antigen testing
The bill would require insurance coverage for the specified testing when used for bone marrow tissue typing.
Multistate employers and unions
The group-policy and health-service-contract requirements would exclude coverage for people employed in more than one state or benefit structures collectively bargained for such workers.
Headline styles
Require Insurance for Bone Marrow Testing
Plain English, a few words. Used as the page title.
Sponsors
No co-sponsors yet.
History
- Referred to insurance
- Referred to insurance
Full text
2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
4798
2023-2024 Regular Sessions
IN ASSEMBLY
February 23, 2023
Introduced by M. of A. PRETLOW -- read once and referred to the Committee on Insurance
AN ACT to amend the insurance law, in relation to requiring policies and contracts of insurance providing hospital, surgical, or medical care coverage to include coverage for human leukocyte antigen testing
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Subsection (i) of section 3216 of the insurance law is amended by adding a new paragraph 39 to read as follows:
(39) Every policy which provides hospital, surgical, or medical care coverage or provides reimbursement for laboratory tests or reimbursement for diagnostic X-ray services shall provide coverage for human leukocyte antigen testing, also referred to as histocompatible locus antigen testing, for A, B, and DR antigens for utilization in tissue typing for bone marrow testing.
§ 2. Subsection (1) of section 3221 of the insurance law is amended by adding a new paragraph 22 to read as follows:
(22) Every group or blanket policy delivered or issued for delivery in this state which provides hospital, surgical, or medical care coverage shall provide coverage for human leukocyte antigen testing, also referred to as histocompatible locus antigen testing, for A, B, and DR antigens for utilization in tissue typing for bone marrow testing, except that this provision shall not apply to a policy which covers persons employed in more than one state or the benefit structure of which was the subject of collective bargaining affecting persons who are employed in more than one state.
§ 3. Section 4303 of the insurance law is amended by adding a new subsection (uu) to read as follows:
(uu) A medical expense indemnity corporation, a hospital service corporation or a health service corporation which provides coverage for hospital, surgical, or medical care shall provide coverage for human
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD09470-01-3
leukocyte antigen testing, also referred to as histocompatible locus antigen testing, for A, B, and DR antigens for utilization in tissue typing for bone marrow testing, except that this provision shall not apply to a contract which covers persons employed in more than one state or the benefit structure of which was the subject of collective bargaining affecting persons who are employed in more than one state.
§ 4. This act shall take effect on the first of January next succeeding the date on which it shall have become a law and shall apply to all policies and contracts issued, renewed, modified, altered, or amended on or after such effective date. Effective immediately, the addition, amendment and/or repeal of any rule or regulation necessary for the implementation of this act on its effective date are authorized to be made and completed on or before such effective date.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.